NCT07039435 Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
| NCT ID | NCT07039435 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Sensorineural Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2024-04-03 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2024-04-03 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency edges than the standard of care default maps. These maps will alternate daily during the first month (with exceptions made for situations when the subject is allowed to use a preferred map rather than the map predetermined for use that day), and after that point each subject will make a selection at the beginning of the week to compare all four maps and decide which one to use at the beginning of the following week. The goal of this study is to investigate how reducing place-pitch mismatch in SSD CI users affects 1) sound quality, 2) device use, and 3) speech perception.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 or older 2. No known anatomical abnormalities in either ear 3. English speaking 4. Intends to receive a cochlear implant in one ear (or has already received it but it has not been activated). 5. Normal hearing (or minimal hearing loss) in the contralateral ear Exclusion Criteria: 1. Under age 18 2. Documented anatomical abnormality of the implanted ear 3. Non-English speaking 4. Greater than minimal hearing loss in the contralateral ear.
Contact & Investigator
Mario A. Svirsky, PhD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT07039435 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sensorineural Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07039435 currently recruiting?
Yes, NCT07039435 is actively recruiting participants. Contact the research team at Mario.svirsky@nyulangone.org for enrollment information.
Where is the NCT07039435 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07039435 clinical trial?
NCT07039435 is sponsored by NYU Langone Health. The principal investigator is Mario A. Svirsky, PhD at NYU Langone Health. The trial plans to enroll 22 participants.